Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas AnalgesiaDermatologyMedical DeviceNeuroscienceOncology & HematologyPediatricsRare DiseaseOtherCOVID-19Cell & Gene TherapyWomen's HealthDiagnosticsReal-World & Late Phase By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Designing Robust Gene Therapy Studies By Jessica Merryfield May 24, 2022 Functional Service Provider (FSP) FSP: The Access Point to Better Clinical Data Management By Cheryl Silva May 18, 2022 Clinical ResearchPhase 1 - Phase 4 IVDR Survival Guide Part 2: Preparing for the NB Bottleneck By Matthew Nowland May 18, 2022 Clinical ResearchPhase 1 - Phase 4 IVDR Survival Guide Part 1: A Deep Dive into Classification, Clinical Evidence, and Performance Requirements By Matthew Nowland May 18, 2022 Clinical ResearchPhase 1 - Phase 4 Pursuing the Promise of Gene Therapy: Pathways to Successful Clinical Trials By Jessica Merryfield May 16, 2022 Clinical ResearchPhase 1 - Phase 4 Maximizing Oncology Study Outcomes: Overcoming Enrollment Challenges in a Phase 2 Prostate Cancer Clinical Trial By Ashley Herrick May 3, 2022 Previous 1 2 3 4 … 47 Next × ALSO OF INTERESTGene Therapy 101: From the 1960s to TodayNostalgia or Shell Shock? Assessing PTSD Is a...Key Considerations When Designing a Phase 1...
